Skip to main content
Clinical Trials/CTRI/2024/11/077213
CTRI/2024/11/077213Not yet recruitingPhase 4

Efficacy of myokinetic active release of trigger points versus dry cupping to reduce back pain and improve quality of life in reducing dysmenorrhea: a randomized clinical trial

Lobsang Chonzom1 site in 1 country46 target enrollmentStarted: March 24, 2025Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
46
Locations
1
Primary Endpoint
Visual Analogue Scale(VAS)

Study Overview

Brief Summary

Dysmenorrhea(painful menstruation)has been prevalent as shown by literature review, therefore it was stated that not much of RCTs has been performed in this particular subject area, also there has been documentation done that Dysmenorrhea is related with low back pain as well particularly involving trigger points in Quadratus Lumborum, Rectus Abdominis and Gluteus Medius musculature as both pelvic area and low back muscles are supplied by same nerve root by its autonomous and peripheral parts. This study will be a comparative study between two Physiotherapy techniques, out of both which shows more efficacy in reducing back pain which will eventually impact Dysmenorrhea and increase the quality of life in young females has been aim and objective of the study. If proven otherwise, the results of the study can be informative for other Physiotherapy community and industrial stakeholders which can be implemented on masses ad can putt light on less explored female-based issues, Dysmenorrhea being one of many.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
17.00 Year(s) to 30.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Females of 17-30 years of age.
  • Subjects experiencing dysmenorrhea.
  • Subjects willing to volunteer for Physiotherapy treatment.
  • Subjects having trigger points in rectus abdominis, quadratus lumborum and gluteus medius.
  • Subjects having regular menstrual cycle.

Exclusion Criteria

  • Fever 2)Inflammatory disease 3)Adenomyosis 4)Polyps 5)Fibroids 6)Post-natal dysmenorrhea 7)Endometriosis 8)Malignancy 9)Oral contraception 10)Ovarian cysts 11)Intrauterine devices 12)Cervical stenosis 13)Any other gynecological conditions.

Outcomes

Primary Outcomes

Visual Analogue Scale(VAS)

Time Frame: Visual Analogue Scale will be assessed at baseline and after the onset of next speculated menstrual period(after 4 weeks)

Secondary Outcomes

  • Menstrual Distress Questionnaire (MEDI-Q)(Menstrual Distress Questionnaire(MEDI-Q) will be evaluated at the baseline & after the onset of next speculated menstrual period(after 4 weeks))

Investigators

Sponsor
Lobsang Chonzom
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Lobsang Chonzom

LOVELY PROFESSIONAL UNIVERSITY

Study Sites (1)

Loading locations...

Similar Trials